Loading data for BLFS — first visit, this takes a few seconds.
BioLife Solutions, Inc. (BLFS)
NasdaqCM: BLFS
· 即時價格 · USD
35.47
-1.60 (-4.32%)
收盤價： Aug 31, 2026, 8:00 PM
37.07
+0.00%
盤前: 8:16 AM
股價、關鍵數字和最新消息，都在這一頁。
BioLife Solutions, Inc.（BLFS）股價、分析與資料
無可用資料
| 買價 | 36.59 |
| 市值 | 1.81B |
| 營收 (ttm) | 107M |
| 淨利（ttm） | 49.2M |
| 1.90 | |
| 1 | |
| 37.07 | |
| 112.33 | |
| P/B (ttm) | 4.31 |
| P/S (ttm) | 16.99 |
| 財報日期 | Aug 12, 2021 |
| 賣價 | 46.5 |
| 成交量 | 945,731 |
| 20 日平均成交量 | 1,106,817 |
| 開盤價 | 36.98 |
| 前收盤價 | 37.07 |
| 當日區間 | 35.12 - 37.25 |
| 52 週範圍 | 17.86 - 38.10 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 BLFS
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media ...
完整的公司簡介財報驚奇
BioLife Solutions 已於 Aug 6, 2026 公布季度財報：
- 營收為 $28.47M 低於預期 $0, 年增 21.45% 成長.
- 每股盈餘為 0.08 超出預期 0.02, 年增 700.00% 成長.
第 1 頁，共 2 頁